Abstract
Background: Cancer is a significant cause of morbidity, mortality, and economic loss in Ireland. It is important that cancer research funding is directed in accordance with the values of a wide variety of stakeholders, so as to ultimately deliver tangible benefits to cancer patients. The aim of this study is to achieve consensus among key stakeholders (including patients, caregivers, healthcare professionals, policymakers and academics) regarding research priorities in the area of early detection of cancer in primary care in Ireland. Methods: A research prioritisation exercise adapted from the James Lind Alliance (JLA) consensus framework will be used to enable all key stakeholders to identify and prioritise research questions. This involves the following stages: (1) setting up a steering group and priority setting partnership, (2) gathering potential research questions via an online survey, (3) processing, categorising, and summarising these research questions, (4) identifying the unanswered research questions, (5) determining the top 10 research priorities via a consensus workshop. Results: The following outcomes will be reported: (1) a “Top 10” list of the most important research questions in early cancer detection in primary care; (2) a list of unanswered research questions which ranked outside of the Top 10; (3) a list of research questions which were proposed but considered to be already answered by a panel of academics working in the field. Conclusions: The co-production of consensus derived research questions in early cancer detection will provide a platform for both funders and researchers to concentrate on the most significant issues to stakeholders, especially patients and their doctors.
Subject
Health Professions (miscellaneous),Medicine (miscellaneous)
Reference36 articles.
1. Cancer in Ireland 1994-2020: Annual Statistical Report of the National Cancer Registry.,2022
2. The case for early detection.;R Etzioni;Nat Rev Cancer.,2003
3. Comparator Report on Cancer in Ireland-Disease Burden, Costs and Access to Medicines.;T Hofmarcher,2022
4. Cost of care for colorectal cancer in Ireland: A health care payer perspective.;L Tilson;Eur J Health Econ.,2012
5. Where does public funding for cancer research go: Allocation of research funding for cancer and COPD is not always proportional to disease burden.;A Trasta;EMBO Rep.,2018